Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",18401,147,1.22 [0.84-1.77],0.3009306776711908
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19348,197,1.00 [0.69-1.46],0.983297540850422
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19122,1393,0.93 [0.80-1.08],0.34603675805851
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,19362,436,1.17 [0.94-1.46],0.1691710980091111
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,18726,3408,1.00 [0.92-1.10],0.9564849956183072
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),18709,3465,1.02 [0.94-1.12],0.6331100364068605
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19123,1151,0.97 [0.83-1.13],0.6764234559539786
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19278,105,0.86 [0.49-1.51],0.5960401159638614
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17093,1013,0.99 [0.83-1.17],0.8748732344448045
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,16480,1222,0.99 [0.85-1.15],0.9083691721266348
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,16125,258,1.01 [0.73-1.39],0.9571715554137344
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,12618,2181,1.02 [0.91-1.14],0.7047911335788999
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,16082,392,1.19 [0.94-1.50],0.1428094948208296
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19330,1358,1.00 [0.87-1.15],0.9813903106783508
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Mycoses,19429,503,1.10 [0.88-1.37],0.3980275809287144
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,18710,981,0.89 [0.75-1.07],0.2233873394072893
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,19372,1118,1.04 [0.89-1.21],0.6022298623212627
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18169,197,1.00 [0.69-1.45],0.9957872727940954
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,19479,49,1.21 [0.62-2.35],0.5801493223865246
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,19232,978,0.97 [0.81-1.15],0.7037218904018319
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19234,61,1.16 [0.63-2.12],0.6350649304448214
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,19428,108,1.31 [0.87-1.98],0.1945358003634775
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19414,94,1.25 [0.79-1.99],0.3417648101800555
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18107,378,0.95 [0.72-1.26],0.7388628554844467
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,17980,251,1.10 [0.81-1.51],0.5433090897320134
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,18074,102,1.03 [0.62-1.72],0.9160130781667511
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,19464,45,0.90 [0.39-2.07],0.7990539463113454
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19419,151,0.84 [0.53-1.34],0.4713661278396979
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral warts,19316,48,0.85 [0.37-1.93],0.7014517456356024
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],19340,72,0.81 [0.41-1.62],0.5582927769175046
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm,19234,218,0.88 [0.60-1.29],0.5201841229781037
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19406,36,1.63 [0.94-2.81],0.0807456595910683
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19392,41,0.61 [0.22-1.68],0.3379444559366865
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,9195,71,0.71 [0.35-1.48],0.364731816844437
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19094,1394,0.99 [0.86-1.14],0.934692822294404
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm of meninges,19465,55,1.03 [0.52-2.02],0.935729999623882
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19402,68,1.20 [0.68-2.10],0.5277386911322822
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,19456,100,1.13 [0.70-1.83],0.6060432946361137
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm of ovary,10232,65,0.81 [0.39-1.66],0.5599549868243703
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,19445,376,1.12 [0.87-1.44],0.3878424320199446
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Caecum,19458,318,1.28 [1.01-1.63],0.0415617881979608
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19357,73,1.61 [1.07-2.41],0.0211545989472867
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,19444,217,0.72 [0.48-1.10],0.1265581561167647
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Rectum,19402,342,0.78 [0.57-1.07],0.1268689882785148
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19346,579,0.99 [0.80-1.24],0.9554741273061694
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,19438,445,1.16 [0.93-1.46],0.1914168779497139
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Carcinoma in situ of breast,7710,44,1.18 [0.60-2.33],0.6251336744410034
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",7741,52,1.14 [0.59-2.20],0.6881078362550629
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",13973,61,0.36 [0.15-0.89],0.0277786911345355
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",13993,81,0.91 [0.50-1.66],0.7544222752573853
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19430,109,1.33 [0.89-1.98],0.162055077617705
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Haemangioma, any site",19431,106,1.33 [0.89-1.99],0.1629125576167181
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Leiomyoma of uterus,10002,147,1.29 [0.90-1.83],0.1605460824653649
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Lung cancer and mesothelioma,12433,421,1.06 [0.82-1.35],0.6680542600061425
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Lymphoid leukaemia,13975,63,0.78 [0.37-1.62],0.5066003401282572
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",14098,186,0.96 [0.65-1.41],0.8197794405874885
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",14169,257,0.78 [0.53-1.12],0.1789579430590324
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",7826,99,1.32 [0.85-2.05],0.2109464557994057
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",14003,91,0.63 [0.32-1.24],0.1823927946149228
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",14029,117,0.80 [0.46-1.38],0.4278624088687408
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",14019,107,1.25 [0.80-1.94],0.3336155987491726
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",7802,75,1.01 [0.55-1.84],0.9782380885950096
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",14022,110,1.02 [0.62-1.66],0.9420194096708798
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",6987,802,0.79 [0.64-0.97],0.0257648029927752
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",14026,114,1.13 [0.72-1.77],0.6023894290358219
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",13989,77,0.79 [0.40-1.56],0.5005497647155621
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,14028,116,1.15 [0.74-1.78],0.5274603973133423
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Melanocytic naevi,19354,159,0.52 [0.30-0.88],0.0150060579904764
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Melanocytic naevi of trunk,19456,67,0.68 [0.44-1.05],0.0820094309273641
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Melanoma in situ,13959,100,0.50 [0.26-0.98],0.0450161832328624
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",14013,101,0.88 [0.51-1.53],0.658943286668799
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",14080,168,0.80 [0.51-1.26],0.3328882214605457
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",14207,295,1.06 [0.78-1.45],0.691569350797921
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",14022,110,0.75 [0.42-1.32],0.3214989573939176
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Other benign neoplasms of skin,19332,144,1.26 [0.87-1.82],0.2165142498552455
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",15137,1225,0.91 [0.78-1.06],0.2324884202682012
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",15203,1291,0.94 [0.81-1.09],0.4273942145122396
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19224,318,0.93 [0.69-1.26],0.6489826763229136
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,17597,107,1.37 [0.92-2.04],0.1180835281040686
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,18965,59,0.84 [0.40-1.78],0.653701551921724
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,18878,2863,0.94 [0.85-1.04],0.2271909484954583
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,18087,59,1.25 [0.69-2.25],0.4607685627483322
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19092,57,1.41 [0.84-2.37],0.1896476764713663
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19088,1598,0.96 [0.84-1.10],0.5664239154460627
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19086,1596,0.96 [0.84-1.10],0.5610529074245809
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,17585,95,1.20 [0.75-1.92],0.4570490730399426
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19182,1154,1.05 [0.91-1.22],0.5170343821905085
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19137,102,1.13 [0.70-1.82],0.6162757206835865
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,18962,56,1.10 [0.56-2.14],0.7798051686631928
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,18975,69,0.33 [0.14-0.79],0.0125956632422715
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,19321,286,1.18 [0.89-1.55],0.2489723810839718
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,19373,31,0.42 [0.12-1.49],0.1813462198641068
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19268,233,1.27 [0.95-1.69],0.1042466360600112
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,18141,113,0.74 [0.42-1.31],0.3011080369846462
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,13170,328,0.78 [0.56-1.09],0.1526980153280342
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18229,87,0.75 [0.38-1.47],0.4072515033830441
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18231,89,1.20 [0.71-2.04],0.4861586845323598
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,12902,60,1.85 [1.29-2.65],0.0007605552721395
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18147,42,0.71 [0.28-1.85],0.4880427093543327
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,17534,261,0.98 [0.70-1.36],0.9067957159930956
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",18854,737,0.91 [0.74-1.11],0.3414461532206625
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,18516,399,0.86 [0.65-1.15],0.3086943774599859
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,18257,140,0.85 [0.53-1.38],0.5180820747122373
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19259,1154,0.94 [0.80-1.10],0.4333983701690266
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,16480,1125,0.95 [0.81-1.11],0.4988224321124519
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",12911,69,1.11 [0.62-2.01],0.7245466899342474
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",17603,87,0.99 [0.57-1.73],0.9813149048222704
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,13143,301,0.78 [0.56-1.10],0.1621344317423809
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,12891,49,0.95 [0.44-2.04],0.8989781638276619
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,16648,3806,1.02 [0.94-1.11],0.6042617087043477
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,13069,227,1.01 [0.72-1.43],0.9356337345890964
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,13432,590,0.91 [0.72-1.14],0.4042074071904529
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19433,298,1.10 [0.83-1.46],0.5157966510918115
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19252,117,1.13 [0.72-1.76],0.6045315479810179
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,12965,123,0.96 [0.60-1.55],0.876056811491881
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",12910,68,1.00 [0.54-1.86],0.994350522167847
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,18951,1435,1.07 [0.94-1.22],0.3193896503301724
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,13140,298,0.88 [0.63-1.22],0.4485416304187795
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,13160,318,0.92 [0.67-1.25],0.5920946506324614
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",13553,711,1.01 [0.83-1.22],0.9296842585754932
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,12967,125,1.15 [0.75-1.75],0.5215234569995122
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19247,112,1.15 [0.73-1.80],0.5436678903925689
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,13583,741,1.16 [0.97-1.38],0.0994675378387318
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,13372,530,1.00 [0.80-1.26],0.977109871500615
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,17332,59,1.02 [0.52-2.00],0.951121521624508
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18186,5344,1.03 [0.96-1.11],0.3853663662336509
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,17566,50,0.78 [0.34-1.81],0.5640057102167513
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,17561,45,1.49 [0.85-2.60],0.1607695187657765
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,19336,1535,1.12 [0.98-1.27],0.097955334260971
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",19334,1533,1.12 [0.98-1.27],0.0894127489935151
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,17567,51,0.97 [0.46-2.06],0.940089090045196
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19181,954,0.92 [0.77-1.10],0.3686084385137014
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",14654,1812,1.02 [0.90-1.15],0.7469603079170573
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,19468,242,1.05 [0.75-1.47],0.7784571000825571
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,18209,92,0.95 [0.54-1.67],0.8656571325971868
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,18327,100,0.75 [0.41-1.37],0.3465581328573073
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,18370,143,0.88 [0.55-1.40],0.5954202048395119
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",13001,159,1.09 [0.74-1.60],0.652565524444123
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17153,150,0.97 [0.63-1.51],0.908700194921562
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2068,81,1.25 [0.68-2.30],0.476223207992804
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2202,248,1.10 [0.78-1.56],0.5847215223480932
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17070,67,1.01 [0.54-1.91],0.9637047263313984
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2035,49,1.39 [0.69-2.83],0.358329639563656
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,18799,1796,1.03 [0.91-1.17],0.6039213707743111
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,18609,492,1.18 [0.96-1.45],0.1233501753991295
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,17635,362,0.98 [0.74-1.29],0.8857856519188816
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,13721,879,1.02 [0.86-1.21],0.8329308020964047
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19366,260,1.14 [0.84-1.53],0.3977573666211548
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),18250,227,1.16 [0.83-1.63],0.3882228264152889
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Angina pectoris,16885,1261,1.02 [0.88-1.18],0.8015269112721319
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,18337,314,0.93 [0.67-1.28],0.6507483071118505
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18091,68,1.63 [1.05-2.55],0.0308269070029038
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",18255,232,1.32 [0.98-1.76],0.0658476603847779
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,9947,2320,0.97 [0.87-1.07],0.5159311788787042
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,AV-block,14946,545,0.91 [0.72-1.15],0.4359373165727793
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19408,464,1.00 [0.78-1.28],0.9952335820679368
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,7846,219,0.71 [0.47-1.07],0.0981987917394724
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,14572,171,0.76 [0.49-1.20],0.2436705785997489
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",14490,89,1.17 [0.73-1.89],0.516302025769892
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,19475,59,1.07 [0.55-2.06],0.84692614130438
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Conduction disorders,15667,1266,1.03 [0.89-1.18],0.7058921088802292
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,17867,2263,1.03 [0.92-1.15],0.5843402680937115
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,15777,7475,0.99 [0.93-1.05],0.7349292243120342
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18191,285,1.12 [0.84-1.49],0.4365371700891833
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Endocarditis,14476,75,0.74 [0.37-1.48],0.396132820356924
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19241,1345,0.96 [0.83-1.11],0.5817982123472267
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Hypertension,16804,6611,0.99 [0.93-1.05],0.7362353456006516
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",16810,6617,0.99 [0.93-1.05],0.7425141143102344
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",19342,83,1.38 [0.87-2.18],0.1746374603964902
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",10426,233,1.03 [0.74-1.43],0.8548516721368905
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,10311,118,0.80 [0.47-1.36],0.4143061147665179
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Hypotension,19330,1287,0.98 [0.85-1.14],0.8105278324205504
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,18434,119,0.96 [0.58-1.58],0.8657722264166956
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18014,2390,1.03 [0.93-1.15],0.5621360299316636
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19071,651,1.16 [0.96-1.40],0.117118300691956
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,14823,422,1.22 [0.98-1.50],0.069597678597891
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,18926,879,1.00 [0.84-1.19],0.9810478267787912
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",16380,756,1.03 [0.85-1.24],0.7764662303820016
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19368,158,1.03 [0.68-1.56],0.8815111750863344
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",19441,343,1.18 [0.91-1.52],0.2058776580725661
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,17964,58,1.31 [0.73-2.34],0.3674753395370387
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other aneurysm,18105,82,1.05 [0.59-1.86],0.8760839165094936
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,14887,486,0.99 [0.78-1.25],0.9319032029117368
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18132,109,1.35 [0.89-2.06],0.1628971645950132
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18293,270,1.42 [1.11-1.81],0.0048252871080886
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,14586,185,0.87 [0.58-1.31],0.5038324056010861
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,17992,86,1.30 [0.81-2.09],0.2750700934005207
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,17943,37,1.13 [0.51-2.53],0.7650721665723181
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,17811,73,0.64 [0.30-1.35],0.23676813842803
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18044,138,1.01 [0.64-1.59],0.9601934500608866
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,15572,1171,1.03 [0.89-1.19],0.7371018646683678
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,18093,50,1.47 [0.85-2.53],0.1645083068958773
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,18617,594,1.25 [1.04-1.51],0.0186386984237863
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,18832,448,1.07 [0.84-1.35],0.5995896086982662
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",18526,788,1.09 [0.91-1.30],0.3493735158051347
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,7974,347,0.89 [0.67-1.18],0.4252052474799223
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,18471,477,1.18 [0.94-1.47],0.1500752768834398
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18260,354,1.09 [0.84-1.42],0.5215216413875007
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,18881,497,1.11 [0.89-1.38],0.3700753149498187
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,19393,785,1.10 [0.92-1.31],0.306924891131401
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,14830,429,0.95 [0.74-1.23],0.7044756164575351
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,18828,444,1.08 [0.85-1.37],0.5450564663717401
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,17950,212,1.07 [0.76-1.52],0.6818119235619919
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19055,740,1.09 [0.90-1.31],0.3726006645812031
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19044,773,1.09 [0.92-1.31],0.3230657502955724
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,18411,50,0.83 [0.36-1.89],0.6579247195895146
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18106,83,0.99 [0.54-1.79],0.9650852771660776
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,18676,256,1.35 [1.04-1.76],0.0245662264233037
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18321,274,0.80 [0.56-1.14],0.2124169128883523
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Varicose veins,18323,417,1.23 [0.98-1.53],0.0700507230392762
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18039,98,1.06 [0.63-1.79],0.8146100384076631
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19242,783,1.10 [0.92-1.31],0.2917643424596118
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19412,278,1.27 [0.97-1.68],0.082552195722517
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",16750,1165,0.89 [0.76-1.05],0.155251832643007
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Any mental disorder,19052,3467,0.97 [0.88-1.06],0.4747385853500013
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19387,327,1.20 [0.92-1.56],0.1721742142871302
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",16759,1174,0.95 [0.81-1.11],0.485522372101001
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",15649,64,0.93 [0.47-1.83],0.8310666336375458
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Smoking dependency,19059,974,1.15 [0.96-1.38],0.1304382619753298
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",16789,1204,1.08 [0.92-1.27],0.3310001009740596
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Vascular dementia,18784,192,0.88 [0.59-1.32],0.5446550307145062
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Alzheimer disease,19476,492,0.99 [0.78-1.25],0.938430996255533
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",12148,92,0.73 [0.39-1.38],0.3327018933434725
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Bell's palsy,17959,71,1.02 [0.55-1.87],0.953444882892584
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18297,409,0.71 [0.53-0.96],0.0277819100260168
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Cerebral cysts,19116,204,1.14 [0.82-1.59],0.4300504164801514
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19415,317,1.11 [0.84-1.47],0.4607003672698729
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,18795,69,1.19 [0.69-2.07],0.5265337869344461
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,19460,60,1.49 [0.92-2.44],0.1082413859540779
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",18981,69,1.20 [0.71-2.05],0.4978469583771399
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Epilepsy,18258,242,0.93 [0.66-1.32],0.7030293558899923
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19105,1089,1.10 [0.95-1.27],0.21561459767753
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,19428,525,0.82 [0.64-1.06],0.1236966740319373
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,18931,2785,1.04 [0.94-1.14],0.471029739761833
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,19180,44,1.22 [0.63-2.35],0.5490624018598467
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Hemiplegia,19358,260,1.10 [0.81-1.50],0.5458444594738829
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Hydrocephalus,18972,60,0.55 [0.23-1.29],0.1691011974431538
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,19464,57,1.15 [0.61-2.15],0.6623529809473678
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,17950,62,0.61 [0.27-1.38],0.238507935123411
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,17952,64,1.00 [0.52-1.93],0.9933570337667862
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Memory loss,18575,129,0.99 [0.63-1.57],0.9686095740727154
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Migraine,18249,233,1.03 [0.74-1.44],0.8536806429732955
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19436,212,0.89 [0.61-1.30],0.540580787137825
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Motor neuron disease,12235,158,1.28 [0.92-1.78],0.150943383479637
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19371,48,1.59 [0.94-2.68],0.085511482051392
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",18894,1006,0.83 [0.69-0.99],0.0407985896655142
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Neurological diseases,18254,3439,0.96 [0.88-1.05],0.3842283065938853
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,18964,238,0.92 [0.65-1.31],0.6427006675608267
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18218,330,0.98 [0.74-1.31],0.9060654324058884
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",19414,280,1.09 [0.81-1.46],0.5790855966858846
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,14791,786,1.03 [0.86-1.24],0.728086180758053
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,18980,68,0.89 [0.45-1.76],0.7280526692789655
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,19041,129,1.24 [0.83-1.85],0.2938694091466603
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19080,177,0.87 [0.57-1.33],0.5195497814085351
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,17966,78,0.91 [0.49-1.70],0.7713628844410876
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other headache syndromes,18062,46,0.57 [0.22-1.50],0.2561194081797434
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other neurological diseases,19384,472,1.08 [0.85-1.35],0.534129773034919
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other sleep disorders,18427,411,1.08 [0.84-1.38],0.5681429319050741
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Parkinson's disease,19446,330,0.79 [0.57-1.09],0.1553283637616107
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,18950,38,1.49 [0.83-2.67],0.1775219682638203
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,19475,77,0.63 [0.31-1.31],0.2195010295407305
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Sleep apnoea,19293,354,1.17 [0.90-1.51],0.2323425707489348
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,19182,48,1.13 [0.56-2.26],0.7331258200530806
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,19464,178,1.29 [0.94-1.78],0.1186464810157003
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,17946,58,0.38 [0.15-0.97],0.0436570090190012
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,19476,497,0.98 [0.77-1.24],0.862412574872863
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),18730,186,0.89 [0.59-1.35],0.5946147096739769
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,18946,126,0.80 [0.47-1.35],0.3970434789847817
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19114,478,1.03 [0.82-1.30],0.7872019796161631
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19273,219,0.89 [0.60-1.31],0.5565236822133959
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,18445,52,0.91 [0.42-1.97],0.8118624870158555
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,18426,33,1.28 [0.60-2.74],0.5236912416857398
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",19374,61,0.72 [0.33-1.58],0.4135445186425227
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19213,192,0.81 [0.53-1.24],0.3338762432702324
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2039,52,1.50 [0.77-2.90],0.2324026377326243
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2513,92,0.96 [0.53-1.74],0.8981106472923982
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,18909,89,0.84 [0.46-1.55],0.5785894650036104
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19242,1181,1.06 [0.92-1.23],0.4343111700507553
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19124,731,1.15 [0.96-1.37],0.1313154664392069
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,18646,253,1.16 [0.86-1.57],0.3232102120363696
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",19421,785,0.99 [0.82-1.19],0.8797450404901299
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,19470,66,0.99 [0.52-1.88],0.9778263315312478
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,19372,736,0.98 [0.81-1.19],0.8657953548198885
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",19444,423,0.89 [0.68-1.16],0.3869477725375658
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,19377,188,0.94 [0.63-1.39],0.7422174069895838
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,18480,87,0.77 [0.41-1.47],0.4343277720282558
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,18479,86,1.39 [0.88-2.20],0.1612130878587738
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,18458,65,1.62 [1.05-2.50],0.0276411132481181
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,19365,849,1.04 [0.87-1.24],0.6769096048582157
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,18751,235,1.10 [0.80-1.50],0.5598057000815794
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,18690,54,0.41 [0.16-1.08],0.0721306592418486
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19125,104,0.91 [0.53-1.56],0.7381875772715434
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,19351,330,0.90 [0.67-1.22],0.507804605355171
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,18820,184,0.96 [0.64-1.43],0.8353525594512686
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19306,117,0.94 [0.57-1.54],0.808233104893656
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19068,552,1.06 [0.86-1.32],0.5611694507596592
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,18952,132,0.98 [0.62-1.54],0.9235506690866
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,17450,2715,1.13 [1.02-1.24],0.0133715374870437
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,19315,294,0.87 [0.63-1.21],0.4032744003957631
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,19461,159,0.89 [0.57-1.39],0.6112287052077461
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,18844,451,1.13 [0.90-1.43],0.2844336431844528
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19097,76,1.20 [0.71-2.03],0.5021858357098345
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,19463,59,1.04 [0.54-2.02],0.907844152015719
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,18499,106,1.11 [0.69-1.79],0.6737049018917401
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,18545,152,1.10 [0.74-1.64],0.6436167205552977
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,18195,134,1.05 [0.68-1.63],0.8149853719317517
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,18679,43,1.40 [0.77-2.56],0.2720446751405895
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",18122,61,0.96 [0.49-1.86],0.8954852695373606
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,18613,97,1.04 [0.62-1.74],0.8704396386187545
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",18759,243,0.98 [0.69-1.37],0.8856118662589221
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,18517,124,1.16 [0.75-1.78],0.506036294086885
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,18138,77,0.76 [0.39-1.50],0.4345009862756475
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,18165,104,1.47 [1.02-2.13],0.0387060726655998
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,16987,2252,0.91 [0.81-1.02],0.1104174961249682
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,18472,79,1.45 [0.93-2.25],0.1035739210323333
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19235,415,0.93 [0.72-1.22],0.6197208787165492
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,18884,64,1.11 [0.60-2.04],0.7404842043049338
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),18980,160,1.19 [0.83-1.71],0.3528184557917302
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19280,91,1.05 [0.62-1.78],0.8480250368390276
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,19440,120,1.03 [0.64-1.65],0.9160923548022124
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,19368,95,1.27 [0.81-2.00],0.302212351483571
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19246,57,1.01 [0.51-2.01],0.9764012032162064
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,19249,60,0.90 [0.44-1.83],0.7629126854097306
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,19383,984,1.03 [0.87-1.21],0.7649361209679294
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19147,748,1.00 [0.82-1.21],0.9637004537443552
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,18523,124,0.95 [0.59-1.55],0.8438639385105877
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,18471,72,1.42 [0.89-2.27],0.1411112441906741
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,19310,52,0.88 [0.40-1.90],0.7373306768651202
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19408,150,0.60 [0.35-1.01],0.0556794732705393
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,19308,50,0.56 [0.22-1.41],0.2183559273031134
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,All influenza,17314,122,1.13 [0.72-1.75],0.5971493460069971
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),17311,119,1.14 [0.73-1.77],0.575334809004646
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),12093,81,1.11 [0.65-1.90],0.7015544601163799
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,19392,198,0.94 [0.64-1.38],0.7656277160018686
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13161,1462,0.99 [0.86-1.14],0.9037892138939336
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",13458,1446,0.99 [0.86-1.14],0.8800452365310036
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19049,149,1.07 [0.71-1.60],0.7603750314177249
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",17275,83,0.98 [0.54-1.77],0.9400094815857636
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Bronchiectasis,16308,428,1.01 [0.78-1.30],0.9336661310732648
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",15939,59,1.05 [0.54-2.05],0.890459204967246
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,18537,2657,1.03 [0.93-1.14],0.5206172609403994
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",18448,66,0.94 [0.49-1.83],0.865209280266756
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,18493,111,1.19 [0.77-1.84],0.4357226114284468
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19234,1351,1.08 [0.94-1.24],0.260666824378492
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,18451,69,0.78 [0.38-1.60],0.4961028306264352
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,17673,5065,1.02 [0.94-1.09],0.6615108218311189
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",18670,288,0.78 [0.55-1.11],0.1747392699492858
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Early onset COPD,17980,97,1.17 [0.71-1.93],0.5394574198806319
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Emphysema,16247,367,1.24 [0.97-1.59],0.080881343595138
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,18361,392,1.01 [0.78-1.32],0.9125119500936892
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19255,2063,1.04 [0.92-1.16],0.5441448118451493
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,18395,426,1.00 [0.78-1.30],0.9739833178137586
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Later onset COPD,19030,1254,1.08 [0.93-1.24],0.3240563029224922
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,19461,372,0.93 [0.70-1.23],0.6106502306334008
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Nasal polyp,18466,84,1.12 [0.67-1.89],0.6605830878665718
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19237,1041,0.98 [0.83-1.15],0.7926014103342051
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,19236,2214,0.97 [0.87-1.09],0.609551954422894
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19016,634,0.93 [0.74-1.15],0.487888283771645
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other pleural conditions,17072,50,1.15 [0.58-2.25],0.693204941013561
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19360,504,0.96 [0.75-1.22],0.7247476730812812
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,19365,1416,0.98 [0.85-1.13],0.7793241583080184
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pleural effusion,18122,1100,0.88 [0.74-1.04],0.1413219855446765
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pleural plaque,17238,216,0.97 [0.68-1.40],0.8786684705655317
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19020,1828,1.01 [0.89-1.14],0.8575032667560745
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,19367,278,0.98 [0.71-1.34],0.8962971226106161
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pneumothorax,17172,150,0.86 [0.54-1.38],0.537495076090744
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pollen allergy,19467,166,0.75 [0.47-1.20],0.2355756242327203
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,18932,76,0.77 [0.39-1.54],0.4623651545873614
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,12069,57,1.08 [0.54-2.15],0.8293354081489737
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19223,1027,0.97 [0.82-1.15],0.7537199317776081
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,18581,199,0.93 [0.63-1.36],0.6984128646036292
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Viral pneumonia,17435,243,1.32 [1.00-1.74],0.0469943866998142
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19061,195,1.27 [0.92-1.74],0.1465909128344511
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,6296,97,0.66 [0.35-1.25],0.2022878991122182
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,12455,53,1.35 [0.76-2.41],0.3024092732394323
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute appendicitis,19375,109,0.74 [0.42-1.33],0.3180563330083809
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute gastritis,13619,82,0.71 [0.36-1.41],0.3237181358717197
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,17788,164,0.74 [0.46-1.18],0.2063543179667527
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute peritonitis,19080,92,1.27 [0.81-2.00],0.3007407228116717
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,18648,48,1.48 [0.86-2.54],0.1591489963509311
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,13954,417,1.01 [0.78-1.31],0.9190986825140366
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",17745,121,1.11 [0.71-1.73],0.6418555122086962
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19132,121,1.11 [0.71-1.74],0.6448204384806948
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Cholecystitis,17800,176,1.05 [0.71-1.54],0.8084385160636852
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Cholelithiasis,18499,875,1.03 [0.87-1.22],0.7462197078916204
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Chronic gastritis,13823,286,0.97 [0.70-1.34],0.8487627229598919
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,17668,44,1.28 [0.67-2.45],0.4549905858922858
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",19365,106,1.46 [1.01-2.13],0.0464087347877851
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Coeliac disease,18034,103,1.05 [0.64-1.72],0.8552829880389855
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Collagenous colitis,18012,88,1.38 [0.90-2.12],0.1390728922942926
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19377,140,1.21 [0.82-1.78],0.3390993327241255
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Constipation,19241,1719,0.95 [0.84-1.09],0.4671940698300585
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Crohn disease,17991,67,1.50 [0.95-2.38],0.0827900059670877
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19184,52,1.42 [0.81-2.48],0.2213649187021172
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,17985,61,1.48 [0.91-2.41],0.1174840606120914
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Dental caries,18954,159,1.10 [0.75-1.63],0.6161187777213157
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,16880,2138,1.05 [0.94-1.16],0.4159024011696914
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of appendix,19401,135,0.97 [0.61-1.53],0.8849145492822366
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of liver,19381,781,1.01 [0.84-1.22],0.8805139629969041
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",17361,3824,1.00 [0.92-1.09],0.993681892042588
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19193,398,1.01 [0.78-1.31],0.9504945732038969
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19402,414,1.24 [0.99-1.54],0.0583408629334391
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,18872,77,0.95 [0.51-1.76],0.8677384704016637
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,18768,46,1.51 [0.88-2.60],0.1377386126352565
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,19205,1274,1.00 [0.87-1.16],0.9538311479619268
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of tongue,18779,77,1.77 [1.25-2.50],0.0012277688284856
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",18891,1267,1.02 [0.88-1.18],0.7724137124966598
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,15579,3177,1.01 [0.92-1.11],0.8329279659999235
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,13736,199,0.60 [0.38-0.96],0.032573261899181
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19393,160,0.50 [0.29-0.86],0.0120629991043874
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19448,19,1.64 [0.81-3.35],0.1714847765724967
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,18724,124,1.34 [0.91-1.95],0.1347139477327278
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,12496,94,1.22 [0.77-1.93],0.4073027358953499
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,14013,476,1.04 [0.82-1.31],0.7679168169688996
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastric ulcer,13894,357,1.20 [0.93-1.54],0.1598115304585015
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,15754,2217,0.96 [0.86-1.08],0.5184586669532955
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,14073,536,0.98 [0.77-1.23],0.8413126170889733
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,14141,6909,1.00 [0.94-1.06],0.9558523854672069
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,GI-bleeding,18978,1047,1.05 [0.90-1.23],0.5571005916974163
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,18839,44,1.05 [0.49-2.24],0.8987976775430273
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,13223,981,0.97 [0.82-1.15],0.7137774529285886
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",18656,56,1.37 [0.78-2.40],0.2768097851092935
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Hernia,17771,3029,0.99 [0.90-1.08],0.7583235482067873
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Impacted teeth,19450,18,1.70 [0.84-3.46],0.1421903120002523
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Impaction of intestines,12464,62,1.05 [0.55-1.98],0.8915180692376582
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Inguinal hernia,15659,917,0.92 [0.77-1.11],0.386817983649245
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",14839,97,1.08 [0.66-1.75],0.7665996520644053
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,12501,99,0.96 [0.56-1.64],0.8884206324236663
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18053,122,0.94 [0.58-1.53],0.8118957124747612
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,12830,428,1.00 [0.78-1.28],0.9719372816337488
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,19453,277,0.95 [0.68-1.31],0.7429648802602355
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,18583,659,1.04 [0.85-1.27],0.7118712320640737
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,18839,915,1.07 [0.90-1.26],0.4444754725395008
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,13719,182,0.95 [0.63-1.42],0.7989043579925248
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Oesophagitis,14126,589,1.04 [0.84-1.28],0.7511724260151087
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19428,113,1.44 [1.00-2.08],0.0497415514043695
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,14812,70,0.77 [0.38-1.55],0.4582303201639371
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,13560,1158,1.04 [0.90-1.21],0.5797386809610688
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,17921,297,0.90 [0.65-1.24],0.5215412886716517
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,17745,121,1.08 [0.69-1.69],0.7440149108760482
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,14009,1607,1.08 [0.96-1.23],0.2072222331768475
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,17545,5143,1.02 [0.95-1.10],0.5889907778976884
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,18752,181,1.35 [1.00-1.83],0.0522423881602335
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of liver,19246,646,1.01 [0.82-1.24],0.9077587678040356
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,14177,640,1.05 [0.86-1.29],0.6165679211664293
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,17800,176,1.15 [0.81-1.64],0.4311400374063872
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19337,349,1.20 [0.94-1.53],0.1499622991730577
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,14461,924,1.04 [0.88-1.23],0.6640010604487966
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,18990,1059,1.05 [0.90-1.23],0.5162676738148606
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,18944,149,1.11 [0.75-1.66],0.5998862755079274
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14158,1756,1.00 [0.88-1.13],0.9796994358007292
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),15339,1802,1.05 [0.93-1.18],0.4374131140234157
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,18696,96,1.26 [0.80-1.98],0.3248562471193214
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,18737,813,1.05 [0.88-1.25],0.6047901887957845
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",12767,365,1.08 [0.83-1.40],0.5536034071950129
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19445,23,1.47 [0.70-3.08],0.3081376165620957
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,12914,512,1.07 [0.86-1.34],0.5294680184410696
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18068,137,0.89 [0.55-1.43],0.6281087421085412
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,19464,43,0.69 [0.27-1.78],0.4449068783781181
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,18789,83,0.73 [0.38-1.42],0.3551258174488302
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Toxic colitis,17993,69,0.63 [0.29-1.37],0.2438796408225804
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,13830,293,1.03 [0.76-1.39],0.8740266061228901
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,18058,134,0.97 [0.61-1.53],0.8815895798911604
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18031,107,0.96 [0.57-1.62],0.8881739109215816
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Umbilical hernia,14949,207,0.68 [0.44-1.06],0.0859838887337749
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,12603,201,0.82 [0.54-1.24],0.3410087765573669
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Ventral hernia,14968,226,1.16 [0.86-1.56],0.3458164389624771
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Volvulus,12477,75,1.15 [0.67-1.98],0.6181195406899374
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,19388,340,0.88 [0.65-1.19],0.4063896004465365
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19174,61,0.64 [0.28-1.45],0.2866576483015652
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,17389,142,0.59 [0.34-1.01],0.055601144607021
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,18960,686,1.14 [0.94-1.37],0.1796866912118591
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18391,117,1.39 [0.95-2.03],0.0908248493920401
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,17730,483,1.09 [0.87-1.36],0.4547974373858934
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19186,259,0.86 [0.61-1.23],0.4085518207555311
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19385,458,0.91 [0.70-1.18],0.465081689093925
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,18970,43,0.65 [0.25-1.69],0.378076788485812
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18127,3082,1.02 [0.93-1.12],0.6527926164487767
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19109,369,1.07 [0.83-1.39],0.5999705700877369
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,18997,257,1.14 [0.85-1.53],0.3934646257467937
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19158,884,1.08 [0.91-1.28],0.3628098614929093
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",19459,51,0.90 [0.42-1.95],0.7948586796299129
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,17302,55,1.12 [0.60-2.09],0.7312502190265462
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,18793,53,1.26 [0.68-2.32],0.4660003303342934
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19174,247,0.85 [0.59-1.23],0.3948030085683389
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,17748,501,0.84 [0.65-1.08],0.1711777339805041
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,17326,79,1.09 [0.62-1.90],0.7643423146558218
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,19407,72,1.10 [0.62-1.95],0.745985507227422
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,18448,174,1.07 [0.73-1.57],0.7281253763111607
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19300,187,1.24 [0.89-1.73],0.2062728134453123
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,18999,72,0.85 [0.43-1.68],0.6369342947349315
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,17307,60,0.40 [0.16-1.00],0.0490706893449619
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,18960,1713,0.96 [0.84-1.09],0.5077290325232916
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",17786,539,0.87 [0.68-1.10],0.2466148992618797
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,17328,81,1.12 [0.65-1.92],0.6899225652354184
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19398,285,1.14 [0.86-1.51],0.3773858039711728
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,18992,65,1.17 [0.66-2.07],0.5845962481679144
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19346,233,1.15 [0.84-1.58],0.3689361221378032
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19416,368,0.94 [0.71-1.24],0.658064509228417
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,17354,107,0.61 [0.33-1.13],0.1171135237015578
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,17521,274,1.10 [0.82-1.47],0.5232247926957003
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19405,357,0.91 [0.68-1.22],0.5215976411695031
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",17505,258,1.04 [0.76-1.44],0.7890345258110445
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,19454,119,1.12 [0.72-1.75],0.6024707021898301
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,16245,66,0.61 [0.27-1.38],0.2359956263622541
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,17184,5378,1.03 [0.96-1.11],0.3808347637682527
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16004,4198,1.03 [0.96-1.12],0.4143806078421105
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,16224,45,1.34 [0.71-2.55],0.3647255510296049
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,16229,118,1.07 [0.67-1.70],0.7775671268658874
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,16268,157,1.15 [0.79-1.67],0.4615755490162138
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19256,50,1.49 [0.88-2.53],0.1385464520372754
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",16235,124,0.65 [0.36-1.15],0.1395743026296113
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,13057,1251,0.99 [0.85-1.14],0.8521427172711914
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19290,209,0.80 [0.54-1.20],0.285521250332614
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,16574,463,1.11 [0.88-1.39],0.3793802579497005
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,15786,6725,1.06 [1.00-1.13],0.0618852765982052
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,17398,102,0.76 [0.42-1.37],0.3558446604015753
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,16326,147,1.34 [0.94-1.90],0.1046694052539026
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,16610,431,1.33 [1.08-1.63],0.0061338783572595
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,18690,2579,1.06 [0.97-1.17],0.2084515832346765
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,16446,267,1.04 [0.76-1.43],0.7951786201028993
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,16300,121,0.82 [0.48-1.39],0.4609017666645331
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,16278,99,1.30 [0.84-1.99],0.2347496123130384
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,18823,87,1.12 [0.68-1.87],0.6553500121103766
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,13485,1679,1.07 [0.95-1.21],0.2689497486148724
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,12438,632,1.10 [0.91-1.34],0.3391573288819591
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19398,626,1.09 [0.89-1.33],0.4172947714940227
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,11865,59,0.67 [0.30-1.51],0.3315343345084902
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),12066,260,1.09 [0.81-1.47],0.5832449900572307
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,16403,224,1.49 [1.16-1.92],0.001629827315226
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,12216,410,1.14 [0.91-1.44],0.2544227334661827
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,16174,63,1.56 [1.00-2.43],0.0513325358634678
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,16671,560,0.94 [0.75-1.18],0.5937890572894342
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,16364,253,0.97 [0.69-1.35],0.8546068636860829
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,12190,384,1.18 [0.94-1.49],0.1550724788093025
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,16237,58,1.14 [0.60-2.18],0.6811351736480526
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",16227,48,1.06 [0.50-2.24],0.8775875127869033
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,17361,65,1.34 [0.79-2.27],0.2741253796264083
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19122,1826,0.97 [0.85-1.09],0.6003206581494566
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,18584,1288,0.96 [0.83-1.11],0.5703642426078298
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19335,452,1.28 [1.04-1.57],0.0190970482801381
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14406,2600,1.06 [0.96-1.17],0.23807267758714
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,11845,39,1.42 [0.77-2.62],0.2632980793820255
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,16263,84,1.57 [1.06-2.33],0.0253372769330206
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,11872,66,1.30 [0.77-2.18],0.3214075211915556
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),11919,113,1.06 [0.67-1.70],0.7938396470760446
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,17501,205,1.15 [0.83-1.60],0.409351781661973
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,17697,401,0.91 [0.69-1.19],0.4715580389135246
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,19459,88,1.12 [0.67-1.87],0.6750333725554108
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",17742,1631,1.06 [0.93-1.20],0.3932533480272919
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,16238,59,0.94 [0.46-1.91],0.8600664771911861
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),11931,125,1.01 [0.64-1.59],0.9605873218134812
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,16766,655,1.03 [0.84-1.26],0.775102005742868
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,13619,1813,1.01 [0.90-1.14],0.8538326770086028
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,18841,105,1.21 [0.78-1.88],0.399673828818359
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,19469,58,0.55 [0.23-1.31],0.1792563165952325
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,16245,66,1.43 [0.87-2.34],0.1565498242240633
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17291,1112,1.05 [0.90-1.23],0.5069331551553521
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,16264,85,1.36 [0.88-2.11],0.163177644727739
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,13542,1736,0.99 [0.87-1.12],0.825235662509519
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,17399,103,1.17 [0.74-1.85],0.4978838161821298
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,16206,27,1.70 [0.95-3.03],0.0715062985276777
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,16273,162,1.29 [0.91-1.81],0.150706419878084
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,16735,556,1.05 [0.84-1.30],0.6898302353237937
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19154,418,0.98 [0.76-1.27],0.8762344649466569
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,16655,544,1.08 [0.87-1.33],0.5023167452572317
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19346,447,1.30 [1.06-1.59],0.0119861699353254
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,19457,57,0.56 [0.23-1.35],0.1980510498581592
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,16318,139,1.47 [1.06-2.02],0.0191206704381691
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,15159,718,0.92 [0.75-1.12],0.4104260475793676
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,16712,533,0.98 [0.77-1.24],0.8550005585731972
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],16420,241,1.08 [0.78-1.50],0.6396694521781986
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",11869,63,1.24 [0.72-2.14],0.4401270047335146
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14408,2602,1.04 [0.94-1.14],0.4720402244872861
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,12503,697,0.98 [0.81-1.20],0.866116194555755
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19048,312,0.94 [0.69-1.27],0.6695622092083007
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",19430,59,1.30 [0.74-2.28],0.3691335804354553
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",17262,58,1.09 [0.57-2.07],0.7960803935998959
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,11865,59,0.62 [0.27-1.42],0.2589111418651379
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,16200,89,0.86 [0.47-1.57],0.6168298339910757
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,12265,459,1.24 [1.01-1.52],0.0356943068717977
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,16460,281,1.30 [1.00-1.68],0.0502449314878328
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,16348,237,1.09 [0.79-1.50],0.5861352575228567
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,16322,211,1.01 [0.71-1.44],0.94711803076875
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,13729,60,0.94 [0.47-1.88],0.8682783345202537
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",19460,60,0.64 [0.28-1.46],0.2884876582593437
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,16645,466,1.19 [0.96-1.48],0.1063655989010461
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],18820,84,1.09 [0.64-1.86],0.7556689756587747
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,18378,2199,1.12 [1.01-1.24],0.0393969274770204
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",16300,121,0.79 [0.46-1.35],0.3820074526898382
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,16682,571,1.13 [0.92-1.38],0.2412916655937291
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,18313,221,1.17 [0.85-1.61],0.3362775055798192
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,16308,197,1.18 [0.84-1.64],0.3402845823937525
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,17736,1625,1.09 [0.97-1.23],0.1631636641914353
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,17170,1059,1.06 [0.91-1.24],0.4517080107603958
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],16227,48,1.61 [0.96-2.67],0.0691096833355312
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,18843,107,1.09 [0.68-1.74],0.717592600998398
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,16324,145,1.34 [0.94-1.91],0.1071941010239536
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,16256,77,0.83 [0.43-1.60],0.5771396520239702
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),11865,59,1.45 [0.88-2.38],0.1464336865726148
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,18368,1782,1.02 [0.90-1.16],0.7155262255837769
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),7867,22,1.41 [0.61-3.25],0.4170127562671046
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,9980,27,1.64 [0.84-3.17],0.1442749222556298
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19205,260,1.17 [0.88-1.57],0.2878822007691821
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19035,90,1.31 [0.83-2.06],0.241936646439655
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18294,1708,1.04 [0.92-1.18],0.523535721413477
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19296,85,1.42 [0.91-2.20],0.12400477736977
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19258,325,1.14 [0.87-1.49],0.3478864499242255
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Cystitis,16346,245,0.98 [0.70-1.37],0.901110972457219
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Dialysis,16653,67,0.75 [0.36-1.58],0.4483639444097655
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,8514,1767,0.91 [0.80-1.04],0.1564541547984473
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,10060,107,0.93 [0.55-1.58],0.7988105776852504
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,7878,33,1.23 [0.56-2.67],0.6064849900346364
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,8329,484,1.15 [0.93-1.42],0.2019253179011458
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,16088,5172,0.98 [0.91-1.06],0.651861190724782
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19278,67,1.41 [0.83-2.37],0.1997766996322023
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,6850,103,1.06 [0.65-1.71],0.8205242905449085
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,16618,273,1.06 [0.78-1.44],0.7140585188871624
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8243,1496,0.89 [0.77-1.03],0.1046406312010845
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,10114,133,1.23 [0.83-1.83],0.2936700349899065
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),6853,106,0.65 [0.35-1.21],0.176377334510441
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,16171,70,0.89 [0.45-1.73],0.7235351520078748
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,8708,863,1.02 [0.86-1.22],0.8091683805108977
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,6799,52,1.01 [0.50-2.05],0.980167930265604
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,7877,32,0.45 [0.13-1.56],0.2101212380938029
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",19470,73,0.63 [0.30-1.33],0.224964901896243
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",19466,67,0.88 [0.44-1.74],0.7103316072515329
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,18477,2376,1.01 [0.91-1.12],0.8499756057768794
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,16886,785,1.01 [0.84-1.21],0.9135146066050268
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,9998,45,0.53 [0.19-1.43],0.2082978693541459
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19418,485,1.14 [0.92-1.42],0.241405972183591
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,6869,122,0.54 [0.29-0.99],0.0466575442542436
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,6879,132,0.76 [0.45-1.29],0.3102919699839904
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,6870,123,0.99 [0.62-1.60],0.97988694452881
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,19447,68,0.61 [0.28-1.33],0.2151357799738593
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,17950,1849,1.01 [0.90-1.14],0.8299489259490984
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,10051,70,1.24 [0.72-2.13],0.436184391392016
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,7909,64,1.11 [0.62-2.02],0.7210598053414772
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",7978,133,0.93 [0.58-1.50],0.7681345816688552
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,7891,46,0.66 [0.26-1.66],0.3790299793038406
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,7930,85,0.95 [0.53-1.70],0.8607734444431733
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,16665,320,1.06 [0.80-1.41],0.678894237662389
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19091,158,1.20 [0.83-1.72],0.3277785785872124
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,7950,105,0.99 [0.59-1.65],0.9594511091200968
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,7866,21,0.99 [0.31-3.11],0.9808246369920094
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,8026,181,0.98 [0.66-1.45],0.9039445157523628
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,7927,82,1.07 [0.62-1.86],0.8046233133610549
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,8022,177,0.95 [0.64-1.43],0.8213714982796507
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19256,45,0.74 [0.30-1.83],0.5165760043044006
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",6871,124,0.77 [0.45-1.32],0.3403187830192751
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19279,2934,1.01 [0.92-1.11],0.818301713931844
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",16420,75,1.17 [0.69-1.99],0.5661092874001332
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,16719,133,1.04 [0.67-1.63],0.84834409953674
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,18978,33,1.49 [0.79-2.84],0.2197898559347194
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,16326,225,1.11 [0.80-1.53],0.5454276357895802
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19282,337,1.25 [0.98-1.59],0.0761226133602949
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,7879,34,0.78 [0.28-2.17],0.6368100678478956
